A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351

• Main Authors: Chunyin Gu (Author), Xiaodan Cao (Author), Zongda Wang (Author), Xue Hu (Author), Yanfeng Yao (Author), Yiwu Zhou (Author), Peipei Liu (Author), Xiaowu Liu (Author), Ge Gao (Author), Xiao Hu (Author), Yecheng Zhang (Author), Zhen Chen (Author), Li Gao (Author), Yun Peng (Author), Fangfang Jia (Author), Chao Shan (Author), Li Yu (Author), Kunpeng Liu (Author), Nan Li (Author), Weiwei Guo (Author), Guoping Jiang (Author), Juan Min (Author), Jianjian Zhang (Author), Lu Yang (Author), Meng Shi (Author), Tianquan Hou (Author), Yanan Li (Author), Weichen Liang (Author), Guoqiao Lu (Author), Congyi Yang (Author), Yuting Wang (Author), Kaiwen Xia (Author), Zheng Xiao (Author), Jianhua Xue (Author), Xueyi Huang (Author), Xin Chen (Author), Haixia Ma (Author), Donglin Song (Author), Zhongzong Pan (Author), Xueping Wang (Author), Haibing Guo (Author), Hong Liang (Author), Zhiming Yuan (Author), Wuxiang Guan (Author), Su-Jun Deng (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19), interacts with the host cell receptor angiotensin-converting enzyme 2 (hACE2) via its spike 1 protein during infection. After the virus sequence was published, we identified two potent ant...